Skip to content
- aflibercept (Zaltrap®)
- axitinib (Inlyta®)
- bevacizumab (Avastin®)
- cabozantinib (Cabometyx®)
- lenvatinib (Lenvima®)
- pazopanib (Votrient®)
- regorafenib (Stivarga®)
- sorafenib (Nexavar®)
- sunitinib (Sutent®)
- vandetanib (Caprelsa®)
- afatinib (Giotrif®)
- cetuximab (Erbitux®)
- erlotinib (Tarceva®)
- gefitinib (Iressa®)
- osimertinib (Tagrisso®)
- panitumumab (Vectibix®)
- alectinib (Alecensa®)
- brigatinib (Alunbrig®)
- ceritinib (Zykadia®)
- crizotinib (Xalkori®)
- lorlatinib (Lorviqua®)
- lapatinib (Tyverb®)
- pertuzumab (Perjeta®)
- T-DM1/ trastuzumab emtansine (Kadcyla®)
- trastuzumab (Herceptin®)
- abemaciclib (Verzenios®)
- palbociclib (Ibrance®)
- ribociclib (Kisqali®)
- dabrafenib (Tafinlar®)
- encorafenib (Braftovi®)
- vemurafenib (Zelboraf®)
- niraparib (Zejula®)
- olaparib (Lynparza®)
- rucaparib (Rubraca®)
- binimetinib (Mektovi®)
- cobimetinib (Cotellic®)
- trametinib (Mekinist®)
- evérolimus (Afinitor®)
- temsirolimus (Torisel®)
- sonidegib (Odomzo®)
- vismodegib (Erivedge®)